FHA is fundamentally an HPO-axis disorder – diminished GnRH leads to low FSH/LH, impaired follicular development, and hypoestrogenism (2) – so future FHA models should measure these hormones and be designed to target such mechanistic pathways. Here, BRD2 is linked to hypoalphalipoproteinemia, primary, 1.